Gil Blum Reiterates Buy on CRISPR Therapeutics, Maintains $82 Price Target on Pipeline Upside and 2026 Data Catalysts
at www.tipranks.com (Wed, 24-Jun 9:15 AM)
CRISPR Therapeutics to Spotlight Expanding Gene-Editing Pipeline at June Investor Conferences
Market Chameleon (Thu, 28-May 8:42 AM)
CRISPR Therapeutics’ Bank of America Conference Appearance Spotlights Industry Leadership and Pipeline Progress
Market Chameleon (Wed, 6-May 8:47 AM)
